HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Dana Dvorakova Selected Research
Dana Dvorakova Research Topics
Disease
9
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2013 - 07/2010
5
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2018 - 02/2012
2
Neoplasms (Cancer)
01/2019 - 05/2006
2
Residual Neoplasm
10/2016 - 11/2015
1
Disease Progression
09/2013
1
Philadelphia Chromosome
11/2010
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2010
1
Carcinogenesis
05/2006
Drug/Important Bio-Agent (IBA)
3
Imatinib Mesylate (Gleevec)
FDA Link
10/2013 - 03/2011
3
Messenger RNA (mRNA)
IBA
02/2011 - 07/2010
2
Nucleophosmin
IBA
10/2016 - 05/2013
2
Tyrosine Kinase Inhibitors
IBA
09/2013 - 06/2012
2
Organic Cation Transporter 1
IBA
09/2011 - 07/2010
1
Transferases
IBA
11/2015
1
DNA (Deoxyribonucleic Acid)
IBA
11/2015
1
Biomarkers (Surrogate Marker)
IBA
11/2015
1
Dasatinib (BMS 354825)
FDA Link
10/2013
1
Phosphotransferases (Kinase)
IBA
06/2012
1
Clofarabine (Clolar)
FDA Link
02/2012
1
Adenosine Triphosphate (ATP)
IBA
02/2011
1
Indicators and Reagents (Reagents)
IBA
11/2010
1
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
05/2006
Therapy/Procedure
3
Therapeutics
01/2019 - 09/2013
1
Heterologous Transplantation (Xenotransplantation)
07/2018